In the long run, InflaRx N.V. (IFRX) Stock makes the most sense financially and strategically
Guggenheim raised the price target for the InflaRx N.V. (NASDAQ:IFRX) stock from “a Neutral” to “a Buy”. The rating was released on April 05, 2023, according to finviz. The research report from Raymond James has upgraded the stock from Outperform to Strong Buy, with a price target set at $14. The stock was upgraded by […]